Friday, August 10, 2012

Tech Stock Alert: Fusion-io (NYSE:FIO) Soars on Fourth Quarter Results

New York, New York - August 10, 2012 (Investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research including tech stocks issues a trading and news alert for Fusion -io (NYSE:FIO) following fourth quarter results. The stock soared to a morning high of $27.48 and is trading at $27.15, up $6.13 or 29.16% as of 10:50AM EDT on over 10 Million shares. The 52- week high for the stock is $41.74.

Summary:
  • Revenue: $359.3 million in fiscal 2012 (an increase of 82% over fiscal 2011)
  • GAAP Net Loss per Diluted Share: 6 cents in fiscal 2012 (compared to earnings of 6 cents in fiscal 2011);
  • Non-GAAP Net Earnings per Diluted Share: 35 cents in fiscal 2012 (compared to 20 cents in fiscal 2011)
  • Operating Cash Flow: $34.8 million in fiscal 2012 (compared to a use of $9.9 million in fiscal 2011)
  • GAAP Gross Margin of 57.5% and Non-GAAP Gross Margin of 57.6% for the fiscal fourth quarter 2012
Investorideas.com Newswire About Fusion-io
Fusion-io delivers the world's data faster. Our Fusion ioMemory platform and software defined storage solutions accelerate virtualization, databases, cloud computing, big data and performance applications. From e-commerce retailers to the world's social media leaders and Fortune Global 500 companies, our customers are improving the performance and efficiency of their data centers with Fusion-io technology to accelerate the critical applications of the information economy.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts. Sectors include biotech stocks, tech stocks, beverage stocks, mining stocks, water, renewable energy, oil and gas.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access 13 online stock directories
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

IPO News Alert: Sports Fans Watch Manchester United (NYSE: MANU) Debut on New York Stock Exchange

New York, New York - August 10, 2012 (Investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research issues a trading alert for the market debut of Manchester United(NYSE :MANU), trading at $14.03, up 0.03(0.21%) at 10:28AM EDT on over 16 Million shares.
The Company’s IPO consisted of 16,666,667 Class A Ordinary Shares at a price of $14.00 per share.
Investorideas.com Newswire About Manchester United
We are one of the most popular and successful sports teams in the world, playing one of the most popular spectator sports on Earth. Through our 134-year heritage we have won 60 trophies, enabling us to develop what we believe is one of the world’s leading brands and a global community of 659 million followers. Our large, passionate community provides Manchester United with a worldwide platform to generate significant revenue from multiple sources, including sponsorship, merchandising, product licensing, new media & mobile, broadcasting and matchday. We attract leading companies such as Nike, Aon and DHL that want access and exposure to our community of followers and association with our brand.
About InvestorIdeas.com:

InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts. Sectors include biotech stocks, tech stocks, beverage stocks, mining stocks, water, renewable energy, oil and gas.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access 13 online stock directories
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com

Thursday, August 09, 2012

Solar Stocks Trading Alert; MEMC Electronic Materials (NYSE:WFR) Gains on Second Quarter Results: Company Sees Improved Solar Business

New York, NY - August 9, 2012 (Investorideas.com renewable energy newswire) Investorideas.com, a leader in renewable energy stock research for independent investors, issues an investor trading alert for solar stock, MEMC Electronic Materials Inc. (NYSE :WFR), trading at $2.48, up 0.20(8.77%) following second quarter results.

Second Quarter 2012 Highlights:
  • GAAP revenue of $808.4 million and GAAP EPS of ($0.27)
  • Non-GAAP revenue of $933.4 million and non-GAAP EPS of $0.14
  • Semiconductor Materials wafer volume grew 10% sequentially
  • Solar Energy segment sold 169 MW of solar energy systems, interconnected 87 MW and ended the quarter with 104 MW under construction
  • Cash and cash equivalents of $448.6 million at quarter end
Revenue in the second quarter of 2012 increased sequentially and year-over-year on improving conditions and operational execution in the company's semiconductor business, and stronger execution in a difficult environment in its solar energy business. Revenue in the company's Semiconductor Materials business grew sequentially driven by higher volume but declined year-over-year due to price erosion and lower volume. Solar Energy revenue rose sequentially and year over year on higher solar project sales. For the second quarter of 2012, SunEdison recognized non-GAAP revenue on 169 MW of solar energy systems sales, compared to 49 MW in the 2012 first quarter and 28 MW in the 2011 second quarter. Despite these increased solar energy systems sales, SunEdison's project pipeline remained flat at 2.9 GW.
Investorideas.com Newswire About MEMC
MEMC is a global leader in semiconductor and solar technology. MEMC has been a pioneer in the design and development of silicon wafer technologies for over 50 years. With R&D and manufacturing facilities in the U.S., Europe, and Asia, MEMC enables the next generation of high performance semiconductor devices and solar cells. Through its SunEdison subsidiary, MEMC is also a developer of solar power projects and a worldwide leader in solar energy services. MEMC's common stock is listed on the New York Stock Exchange under the symbol "WFR." For more information about MEMC, please visit www.memc.com.
Research more cleantech stocks on global stock exchanges -and up to 1400 at Investorideas.com renewable energy stocks stock directory
About Investorideas.com - a leader in cleantech investor research
www.Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Follow Investorideas.com on Twitter
Follow Investorideas.com on Facebook
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 24/7 Login to 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks, tech and more.
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp Investorideas.com was not compensated for this report and does not hold a position in the stock
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com
contact:
800.665.0411

Electric Car Stocks; EVCARCO, Inc. (OTCBB: EVCAD) Announces Management Change

FORT WORTH, TX – August 9, 2011 (Investorideas.com renewable energy/green newswire) - EVCARCO, Inc. (OTCBB:EVCA) announced today that Executive Vice President, Walter Speck has acquired a controlling interest in the Company. Mr. Speck has purchased 7,000,000 shares of Class B Convertible Preferred Stock from Nikolay Frolov, CFO and former Director of EVCA. Mr. Frolov recently resigned from the position of Director of the Company.

Mr. Gary Easterwood, President and CEO of EVCARCO/Third Stone Corporation has been appointed to the position of Director to fill the existing vacancy. Mr. Speck has been elected Chairman of the Board of the Company.
Mr. Speck commented, "This is an exciting development for EVCARCO and its subsidiary, The Third Stone Corporation. As Officer and Director, my objective will be to provide the leadership to put the Company on a path to success."
Mr. Easterwood stated, "The stock purchase finalizes the merger with EVCARCO and The Third Stone Corporation. Now that we have completed this step, we can begin implementing our plan to bring EVCA/The Third Stone Corporation to health and profitability. We will have exciting news to share with our stockholders in the coming weeks."
For more information on The Third Stone Corporation, Inc., please view: www.thirdstonecorp.com. Shareholder inquiries should be directed to (972) 571-1624.
For more information on EVCARCO, Inc., please view: www.evcarco.com. Shareholder inquiries should be directed to (972) 571-1624.
EVCARCO, Inc. is a Future Driven® Automotive Retail Group focused on deploying a coast-to-coast network of environmentally friendly franchised dealerships, vehicles, technologies and sustainable solutions. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles from multiple manufacturers. EVCARCO also owns The Third Stone Corporation, a forward-thinking software provider dedicated to improving and enhancing lives through innovations of software development and data services for sport, financial, home automation and social networking.
Forward-Looking Statement
This release contains forward-looking statements that reflect EVCARCO, Inc. plans and expectations. In this press release and related comments by Company management, words like "expect," "anticipate," "estimate," "forecast," "objective," "plan," "goal" and similar expressions are used to identify forward-looking statements, representing management's current judgment and expectations about possible future events. Management believes these forward-looking statements and the judgments upon which they are based to be reasonable, but they are not guarantees of future performance and involve numerous known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance, achievements or financial position to be materially different from any future results, performance, achievements or financial position expressed or implied by these forward-looking statements.
Contact:
Investor Relations
Jack Eversull
The Eversull Group, Inc.
972-571-1624
214-469-2361 fax
Published at the Investorideas.com Newswire
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp. Investorideas.com Disclosure: Investorideas.com is compensated for publishing and distributing news for EVCA: five hundred thousand shares for a 3 month period starting July 27th 2012.
All investment involves risk. Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Biotech Stock Alert; Aethlon Medical (OTCBB: AEMD) Announces Expanded Access to Hemopurifier® Therapy For Individuals Infected with Hepatitis C Virus (HCV)

SAN DIEGO - August 9, 2012 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that it has agreed to establish a treatment program that will provide HCV-infected individuals with expanded access to Hemopurifier® therapy. The program is being initiated with support from the Institutional Review Board at the Medanta Medicity Institute (Medicity) to allow compassionate usage of the Aethlon Hemopurifier® for individuals who previously failed or subsequently relapsed standard-of-care drug regimens.

In addition to offering Hemopurifier® therapy to the citizens of India, HCV-infected individuals from the United States, European Union and other regions of the world may pursue treatment through the expanded access program. Details related to treatment protocol, inclusion criteria, patient approval processes and therapy pricing are anticipated in September. It is estimated that approximately 170 million people worldwide are infected with HCV, which leads to chronic liver disease or cirrhosis, and is a leading cause of liver transplantation.
The Aethlon Hemopurifier® is a first-in-class medical device that selectively targets the rapid clearance of HCV from the entire circulatory system to improve benefit, dose, duration and tolerability of drug therapies. The Medicity is a $360 million multi-specialty medical institute established to be a premier center for medical tourism in India.
"The Medicity access program represents an important milestone in our quest to establish the selective therapeutic filtration industry," stated Aethlon Chairman and CEO, Jim Joyce. "Beyond helping HCV-infected individuals overcome their disease, we now have the opportunity to augment our established government contract revenues with Hemopurifier® product sales."
Aethlon also disclosed that it will continue conducting a study at the Medicity that is evaluating the capability of the Aethlon Hemopurifier® to accelerate HCV RNA depletion at the outset of standard of care peginterferon+ribavirin (PR) therapy. Specifically, HCV-infected individuals are enrolled to receive up to three, six-hour Hemopurifier® treatments during the first three days of PR drug therapy. Last week, Aethlon reported that the two most recent HCV infected patients to receive Hemopurifier® therapy in combination with PR drug therapy achieved undetectable viral load at day-7, which is rarely reported in drug therapy alone.
The primary clinical endpoint of the Medicity protocol has been to increase the incidence of rapid virologic response (RVR), defined as undetectable HCV RNA at day 30 of therapy. RVR represents the clinical endpoint that best predicts treatment cure, otherwise known as sustained virologic response (SVR), defined as undetectable HCV RNA 24-weeks after the completion of PR drug therapy. As a point of reference, the landmark IDEAL Study of 3,070 HCV genotype-1 patients documented that only 10.35% (n=318/3070) of PR treated patients achieved a RVR. However, patients that achieved a RVR had SVR rates of 86.2% (n=274/318) versus SVR rates of 32.5% (n=897/2752) in non-RVR patients. While the incidence of undetectable HCV RNA at day-7 is not reported in the IDEAL study, the study did reveal that just 4.3% (n=131/3070) of patients achieved undetectable HCV RNA at day-14, which equated to a 91% (n=118/131) SVR rate.
Aethlon reported that Hemopurifier® therapy has been well tolerated and without device-related adverse events in ten treated patients. Of these ten patients, seven patients were infected with HCV genotype-1; two patients were infected with HCV genotype-3; and one patient was infected with HCV genotype-5. At present, undetectable HCV RNA is reported in eight of the 10 treated patients. Of the two patients with detectable HCV RNA, one discontinued PR therapy as a result of a diabetes related condition. HCV RNA is undetectable in all patients (n=4) that have been monitored for 48 weeks since receiving Hemopurifier® therapy. Among the 10 treated patients, Aethlon reported that six genotype-1 patients received the three treatment Hemopurifier® protocol, which resulted in four (67%) patients achieving a RVR. The IDEAL study predicts it would normally require approximately 40 PR treated patients to achieve 4 RVR outcomes. Both patients who achieved undetectable HCV RNA at day-7 also achieved a RVR. Beyond the high likelihood of a SVR, genotype-1 patients that achieve a RVR also have the opportunity to reduce the duration of PR drug therapy from 48 weeks to 24 weeks.
In addition to expanding access to Hemopurifier® therapy at the Medicity, Aethlon is preparing to resubmit to the FDA an investigational device exemption (IDE), which will incorporate the Medicity data in an effort to gain approval to initiate HCV clinical programs in the United States.
Investorideas.com Newswire
About Aethlon Medical
The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with the Defense Advanced Research Projects Agency (DARPA) that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the ability for the Company to derive business partnerships or future revenue streams using the Aethlon ADAPT™ system including the ability to introduce a targeted breast cancer therapy known as HER2osome™, there is no assurance that FDA will approve the initiation of the company's clinical programs or provide market clearance of the company's products, the ability to achieve the goals set out in the DARPA contract, future human studies of the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer therapies, the company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Visit the AETHLON MEDICAL INC (OTC BB: AEMD) showcase profile page on Investorideas.comDisclosure/Disclaimer: AETHLON MEDICAL INC (OTC BB: AEMD) Investorideas.com is paid by AEMD to publish news and distribute content through Investordeas.com Newswire and its syndicated partners and blogs

Wednesday, August 08, 2012

IPO Trading Alert: Bloomin' Brands (NASDAQ:BLMN) Gains in Market Debut

New York, NY - August 8, 2012 (Investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research including food and beverage stocks reports on the IPO market debut for Bloomin' Brands Inc. (NASDAQ: BLMN). The stock is trading at $12.31, up 1.31(11.95%) 11:13AM EDT on over 6.5 Million shares.
The IPO consisted of 16,000,000 shares at $11.00 per share; 13,000,000 shares from the Company and certain selling stockholders will offer 3,000,000 shares.
Investorideas.com Newswire

About Bloomin' Brands Inc. (NASDAQ: BLMN)
Bloomin' Brands is a portfolio of brands comprised of Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, Fleming's Prime Steakhouse & Wine Bar and Roy's with more than 1,400 restaurants in 48 states and 20 countries and territories internationally
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
Become an Investorideas.com Member and access 13 online stock directories
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Nanotechnology Stocks; mPhase (OTC.BB:XDSL) to Explore Possibility of Complementing Its Smart NanoBattery With New Printing Technologies Utilizing Graphene and Other Advanced Materials

LITTLE FALLS, NJ - August 7, 2012 (Investorideas.com Newswire) - mPhase Technologies, Inc. (OTC.BB: XDSL.OB) said today that it is exploring complementing its Smart NanoBattery with new printing technologies utilizing Graphene and other advanced new materials.

On July 17, 2012, mPhase announced an official agreement to jointly pursue business opportunities with government projects involving the research of Graphene based methods for the ink jet printing of batteries and electronic circuits with a leading technology University.
Successfully implementing mPhase's Smart NanoBattery Technology with new material and printing technologies could lead to better energy densities, more flexible structures, lower prototyping costs and lower production costs.
Graphene has been described as the "miracle material" of the 21st Century and is believed to be stronger than steel and more conductive than copper while being flexible, making it plausible as a vast improvement over silicon possibly leading to thinner, faster, cheaper, more flexible devices including power sources. Since Graphene comes from the carbon atom it is abundant and cheap.
In 2010 the Nobel Prize in Physics was awarded to Andre Geim and Konstantin Novoselov for groundbreaking experiments regarding graphene.
For more information on graphene:
BBC News - Is graphene a miracle material?
About mPhase Technologies, Inc.
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery. In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website: http://www.mPhaseTech.com.
Forward-Looking Statements
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. mPhase assumes no obligation to update the information in this release.
Contact:
973-256-3737
mPhase Technologies, Inc.
Visit the XDSL showcase profile at Investorideas.com
Request News and Info on XDSL
Disclosure, Disclaimer/ XDSL is a paid advertising client on Investorideas.com and our technology portals.

Beverage Stock Interview with DC Brands (OTC: HRDN); Revolutionizing the Functional Beverage Market

New York, New York - August 8, 2012 (Investorideas.com newswire, www.beveragestocks.com) Investorideas.com, an investor research portal specializing in sector research including beverage and health stocks issues an exclusive Q&A with Stephen F. Horgan, CEO of DC Brands International (OTC: HRDN) , and Robert “Dr. Bob” Nikkel, Chief Herbologist. Mr. Horgan and Dr. Bob discuss the Company’s product line and the growth strategy in the functional beverages and nutritional supplement categories.

Q: Investorideas.com staff
Investors aware of the growing global trend of eating and drinking healthier have watched the success of stocks like Whole Foods Market, Inc. (NasdaqGS :WFM) . Can you give investors some insight as to why your company chose to focus on the functional beverage and nutritional supplements sector?
A: Stephen F. Horgan, CEO (SFH)
The total non alcohol beverage market is over $110 Billion dollars in the US. Functional Beverages are approaching $15 Billion of that total. Our history is in nutritional supplements, which is where everything with our products emanates from. With the development of our proprietary flip-top cap delivery system, we were able to cross over into certain beverage occasions of nutrition conscious consumers. Our supplements provide a variety of solutions for these consumers looking for optimal nutrition delivery versus the minimal daily requirements. This is the case both with our dry line as well as our beverage line.
Q: Investorideas.com staff
You recently announced a distribution agreement that will potentially provide HARD Nutrition access to tens of thousands of retail outlets nationally. Can you give investors insight into the rollout of this agreement?
A: SFH
Our first priority will be to penetrate bell weather beverage markets geographically. This would mean Southern California initially, and eventually NYC. Our product has historically only been available in Colorado and it is time we moved outward from here to diversified markets with broader reach. Concurrently, we will begin speaking with national retailers about our products and the unique benefits it offers to their customers. The cycle on the former is much faster than on the latter so we would expect to see geographic progress ahead of national retail progress.
Q: Investorideas.com staff
Very few of the large domestic and international beverage companies have taken the steps to add stevia as a healthy sugar substitute. It appears to be a growing trend with some of the smaller niche beverage companies . Can you tell investors why you chose to have stevia added into your new reformulated drinks?
A: Dr.Bob Nikkel
The reason Hard Nutrition uses Stevia is because it is the only natural plant source that provides the sweetness taste in an all natural way without any calories, or side effects.
Q: Investorideas.com staff
In addition to your functional beverage product line you also have a wide array of nutritional supplements and vitamins to offer consumers. Can you give investors some insight on how you are continuing to develop and revamp these products?
A: Dr. Bob
We maintain a close watch on market and product developments as well as continually improving our products. Therefore are very aware of all new products, research their properties, constituencies and efficacy, and if we believe there is a component that can improve any of our formulas, in the interest of delivering consumer value and benefit, we will adapt as necessary.
Q: Investorideas.com staff
Can you explain to investors what sets your drinks apart from some of the larger health and vitamin beverage competitors?
A: Dr Bob.
The very obvious difference is that we deliver true functions, with all natural vitamins and herbal supplements for maximum efficacy. We have a patented delivery system that is distinctive and separates the beverage, or hydration aspect, and the dry supplement and vitamins. By doing this we deliver the function that the consumer desires, in a very flavorful and satisfying way.
When vitamins and supplements are added to the liquid the efficacy is reduced or even eliminated, due to heat applications for pasteurization. Moreover, the resultant taste of a drink when the vitamins and beverage are combined fails to meet the consumers expectations.
It is this unique and patented delivery flip-top cap system that really sets us apart. If you try to put enough nutrition in the drink you will get either a pungent and harsh taste, or so much masking flavor (sugar) will have to be added to make it taste pleasant that you negate the benefits the consumer is seeking. The maximum amount of nutrition that can be added into a drink is about 10% without resulting in a very harsh taste. This is why we separated the drink and the vitamin supplements in creating this first functional beverage system.
Q: Investorideas.com staff
In closing, can you give investors insight into your overall growth strategy for this year?
A: SFH
As soon as I began in June we immediately created 4 separate divisions for the company; Functional Beverage, Dry Supplements, Online and International. Although beverages will get most of the press, we expect that our Southern California and retail efforts in beverages will initially be enhanced by growth in our Dry Supplements and Online Divisions. International will be slower in developing and will take about a year before it will begin to contribute. We expect to be in the market with our new distinct, eye catching packaging in 30 days. We will also implement a very aggressive grass roots online, social media networking marketing approach to gain local consumers, and use that traction to expand the distribution network into other national markets that we believe have a consumer base that will embrace our nutritional dry and beverage products.
DC Brands International, a publicly traded company under the ticker symbol (HRDN), presently specializes in the manufacturing of its functional beverages and health products. Established in 1998, DC Brands began producing a number of lines of energy drinks in 2005. DC Brands then purchased the assets of H.A.R.D. Nutrition and began its quest to produce a new health line of products. DC Brands has recently announced the release of its new H.A.R.D. Nutrition Functional Water Systems, which it expects will revolutionize the functional beverage category. www.hardnutrition.com .
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
http://www.investorideas.com/About/Disclaimer.asp
Disclosure: Investorideas.com and its SMS partner Running Bull OTC have been compensated by HRDN for one month of news, email and sms: twenty five thousand
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
DC Brands is featured on Running Bull OTC for SMS alerts - sign up for the ap with your iphone or Android; Blackberry coming soon!
http://www.runningbullotc.com/
Contact HRDN: Wade Brantley
wbrantley@dc-brands.com
Contact Invesstorideas.com 800 665 0411
Source: Investorideas.com, DC Brands International

Monday, August 06, 2012

Biodefense Stock News; Northrop Grumman (NYSE:NOC) and PositiveID (OTCBB: PSID) Prepare for BioWatch Procurement

New York, New York - August 6, 2012 (Investorideas.com newswire, www.biodefensestocks.com) Investorideas.com, a leader in research for independent investors issues a news alert for biodefense stocks, PositiveID Corporation (OTCBB: PSID) and Northrop Grumman Corporation (NYSE:NOC) as both companies prepare for technology acquisitions and procurement for BioWatch Generation 3 this fall.

PositiveID Corporation (OTCBB: PSID) recently reported it added Dr. Kimothy Smith as Chief Technology Advisor to the Company and its Microfluidic Systems ("MFS") subsidiary. The Company will utilize Dr. Smith's expertise in the areas of biosurveillance, biodefense, biosecurity, molecular genetics and diagnostics, as it prepares for the release of the final request for proposal from the Department of Homeland Security ("DHS") for BioWatch Generation 3,  a $3.1 billion procurement for an early warning system designed to detect the intentional release of airborne biological agents. The Company believes its M-BAND system is one of the only technologies capable of addressing the requirements of BioWatch Generation 3.
In July Northrop Grumman Corporation (NYSE:NOC) reported  that its Next Generation Automated Detection System (NG-ADS) for homeland defense applications has successfully completed a rigorous field test and is ready for the program's next phase.
The NG-ADS technology is a competitor for the Department of Homeland Security's (DHS) upcoming BioWatch Gen-3 Phase II acquisition. The program seeks to deploy a nationwide network of fully autonomous bio-detectors in major metropolitan areas across the United States to provide early warning of a biological attack. DHS recently announced that a request for proposals will be issued later this year.
As a fully automated biological detection system, the NG-ADS continuously collects air samples, analyzes the samples for the presence of multiple biological pathogens, and automatically reports results to public health officials multiple times each day through a secure data network. More than 20,000 samples were collected and analyzed during the recent field test in a variety of indoor and outdoor locations in a major city in the United States .
"There are concerns that our nation won't be ready to respond should a biological attack occur," said Dave Tilles, director of Homeland Security programs at Northrop Grumman's Electronic Systems sector. "Early warning provided by an automated detection system such as the NG-ADS will allow the nation's public health and public safety officials to proactively manage the response to a biological event to reduce exposure and treat the affected population to minimize casualties."
Since the successful field test, additional improvements have been made to the NG-ADS to enhance the system's performance while reducing its life-cycle cost. The proven, life-saving capability of the NG-ADS draws upon Northrop Grumman's decade long experience developing, testing, deploying, and operating bio-detection systems for the U.S. government and other customers.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of advanced technologies for diabetes management and rapid medical testing, as well as airborne bio-threat detection systems for America 's homeland defense. Its wholly-owned subsidiary, Microfluidic Systems, or MFS, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. www.PositiveIDCorp.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Read Investorideas.com on Linkedin.com/today
http://www.linkedin.com/today/investorideas.com
Get free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer /Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. .More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: PositiveID Corporation  compensates Investorideas.com for news release publication, syndication on blogs and related sites and email distribution and  company profile: renewed July 2012 -3500 cash and five hundred thousand shares for three months http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact
PSID:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Investorideas.com:
Contact: 800 665 0411

Investorideas.com News now Featured on Linkedin.com/Today

New York, New York - August 6, 2012 (Investorideas.com newswire) Investorideas.com, an investor research portal specializing in sector research for independent investors is pleased to report the Investorideas.com news content is now featured on Linkedin.com/today . Investorideas.com is now an approved news and publishing source at Linkedin.com/today.

http://www.linkedin.com/today/ investorideas.com
About http://www.linkedin.com/today/
The day's top news, tailored for you
About LinkedIn (LNKD)
Founded in 2003, LinkedIn connects the world's professionals to make them more productive and successful. With more than 175 million members worldwide, including executives from every Fortune 500 company, LinkedIn is the world's largest professional network on the Internet. The company has a diversified business model with revenue coming from member subscriptions, marketing solutions and hiring solutions. Headquartered in Silicon Valley, LinkedIn also has offices across the Americas, Europe, and the Asia-Pacific.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; water and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, natural gas stocks, tech (includes cloud and social networking), defense stocks, nanotech, China stocks and agriculture.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Sign up for the free investor news letter and stock alerts at Investorideas.com http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com wire is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investment involves risk and potential loss of all investment
Contact Investorideas.com
800 665 0411

Friday, August 03, 2012

Social Networking Stocks; Linkedin.com (NASDAQ:LNKD) Soars on Second Quarter Results

New York, NY - August 3, 2012 (InvestorIdeas.com Newswire) Investorideas.com staff reports on Linkedin.com (NASDAQ: LNKD). InvestorIdeas.com, a global investor research portal, specializing in sector research including tech stocks and social media stocks reports on trading for Linkedin.com (NASDAQ: LNKD) following second quarter results reported on Thursday. The stock had a morning of $107.98 and is currently trading at $104.89, up $11.38 or 12.17% on just under 5 Million shares.

Investors reacted to the dramatic jump in revenue of 89% compared to the second quarter of the previous year. This is also a stock Wall Street relates to as most of the investment community are now members of the growing business social media community and part of the 175 Million users at Linkedin.com.
Second Quarter Results Summary
  • Revenue for the second quarter was $228.2 million, an increase of 89% compared to $121.0 million in the second quarter of 2011.
  • Net income for the second quarter was $2.8 million, compared to net income of $4.5 million for the second quarter of 2011. Non-GAAP net income for the second quarter was $18.1 million, compared to $10.8 million for the second quarter of 2011. Non-GAAP measures exclude tax-affected stock-based compensation expense and tax-affected amortization of acquired intangible assets.
  • Adjusted EBITDA for the second quarter was $50.4 million, or 22% of revenue, compared to $26.3 million for the second quarter of 2011, or 22% of revenue.
  • GAAP EPS for the second quarter was $0.03; Non-GAAP EPS for the second quarter was $0.16.
Investorideas.com Newswire About LinkedIn
Founded in 2003, LinkedIn connects the world's professionals to make them more productive and successful. With more than 175 million members worldwide, including executives from every Fortune 500 company, LinkedIn is the world's largest professional network on the Internet. The company has a diversified business model with revenue coming from member subscriptions, marketing solutions and hiring solutions. Headquartered in Silicon Valley, LinkedIn also has offices across the Americas, Europe, and the Asia-Pacific.
Investorideas.com was recently approved as a Linkedin.com/today publisher and will be live shortly at www.Linkedin.com/today/investorideas
Research Social Networking stocks:
Social Networking Stocks Directory preview page:
http://www.investorideas.com/TSS/Social_Networking_Stocks.asp
Sign up for the free investor news letter and stock alerts at Investorideas.com http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; water and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, natural gas stocks, tech (includes cloud and social networking), defense stocks, nanotech, China stocks and agriculture.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
Source - Investorideas.com
800-665-0411

Social Media Stock News; Something to YELP about in Social Media Stocks

New York, NY - August 3, 2012 (InvestorIdeas.com Newswire) Investorideas.com staff reports on tech stocks. InvestorIdeas.com, a global investor research portal, specializing in sector research including tech stocks and social media stocks, reports on recent trading and news for YELP (NASDAQ:YELP). On Wednesday after the bell, the Company reported its second quarter results. In Thursday's trading session the stock gained 17%.

The stock is still rallying in this morning's trading with a morning high of $23.35. The stock has pulled back but is still in the green for investors. YELP (NASDAQ:YELP). and Linkedin.com (NASDAQ: LNKD) are both showing investors that there are still gains to be made in the sector, following the disappointment of Facebook's entrance to the market.
Second Quarter Summary:
  • Net revenue was $32.7 million in the second quarter of 2012, reflecting 67% growth in net revenue from the second quarter of 2011
  • Cumulative reviews grew 54% year over year to more than 30 million
  • Average monthly unique visitors grew 52% year over year to more than 78 million*
  • Active local business accounts grew 113% year over year to approximately 32,000
Net loss in the second quarter of 2012 was $(2.0) million or $(0.03) per share, compared to a net loss of $(1.2) million, or $(0.08) per share, in the second quarter of 2011. Adjusted EBITDA for the second quarter of 2012 was approximately $1.6 million, compared to $649,000 for the second quarter of 2011.
Investorideas.com Newswire About Yelp:
Yelp Inc. connects people with great local businesses. Yelp was founded in San Francisco in July 2004. Since then, Yelp communities have taken root in major metros across the US, Canada, UK, Ireland, France, Germany, Austria, The Netherlands, Spain, Italy, Switzerland, Belgium, Australia, Sweden, Denmark, Norway and Finland. Yelp had a monthly average of approximately 71 million unique visitors in Q1 2012.** By the end of the same quarter, Yelpers had written approximately 27 million rich, local reviews, making Yelp the leading local guide for real word-of-mouth on everything from boutiques and mechanics to restaurants and dentists. Yelp's mobile applications were used on approximately 6.3 million unique mobile devices on a monthly average basis during Q1 2012.
Research Social Networking stocks:
Social Networking Stocks Directory preview page:
http://www.investorideas.com/TSS/Social_Networking_Stocks.asp
Sign up for the free investor news letter and stock alerts at Investorideas.com http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Become an Investor Ideas Member Today - Get 24/7 access to our exclusive members only - 13 stock directories; energy, renewable energy, mining stocks, water, biotech. Added bonus for members - New Tech Stocks Directory for Social Networking and Cloud Computing Stocks
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
Source - Investorideas.com
800-665-0411

Thursday, August 02, 2012

Beverage Stock Trading Alert; DC Brands (OTC: HRDN) Gains over 70%

New York, New York - August 2, 2012 (Investorideas.com newswire, www.beveragestocks.com) Investorideas.com, an investor research portal specializing in sector research including beverage stocks issues a trading alert for DC Brands International Inc. (OTC: HRDN) for the close of trading August 1st.
The stock closed up at $0.0060, gaining $0.0025 or 71.43% on over 1 Million Shares. The most recent news from the Company in late June reported it entered into an agreement with a national sales and brokerage company, that will give its functional water systems and supplement products access to local and national retailers across multiple channels including Walgreens, Costco, and the major national grocery chains.
Investorideas.com Newswire DC Brands International, a publicly traded company under the ticker symbol (HRDN), presently specializes in the manufacturing of its functional beverages and health products. Established in 1998, DC Brands began producing a number of lines of energy drinks in 2005. DC Brands then purchased the assets of H.A.R.D. Nutrition and began its quest to produce a new health line of products. DC Brands has recently announced the release of its new H.A.R.D. Nutrition Functional Water Systems, which it expects will revolutionize the functional beverage category. www.hardnutrition.com.
DC Brands is featured on Running Bull OTC for SMS alerts - Sign up now!

http://www.runningbullotc.com/
Published at www.investorideas.com newswire
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas.com and its SMS partner Running Bull OTC have been compensated by HRDN for one month of news, email and sms: twenty five thousand
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source: Investorideas.com, DC Brands International
Contac HRDN: Wade Brantley
wbrantley@dc-brands.com
Contact Investorideas.com 800 665 0411

OTC Beverage Stocks to Watch: (OTCBB: AHFD), (OTCBB: HRDN), (OTCBB: HJOE), (OTCBB: TEMO)

New York, New York - August 2, 2012 (Investorideas.com newswire, www.beveragestocks.com) Investorideas.com, an investor research portal specializing in sector research including beverage stocks issues an alert OTC beverage stocks making notable gains.

Active Health Foods, Inc. (OTCBB: AHFD) is trading up today at $0.0044, gaining $ 0.0014 or 46.67% 11:33AM EDT on over 12 Million shares. The Company announced today a major distribution deal for its "All Natural Flavors", a sparkling, flavored, sugar free beverage.
DC Brands International Inc. (OTC: HRDN) closed up at $0.0060, gaining $0.0025 or 71.43% on over 1 Million Shares in yesterday’s trading session .The most recent news from the Company in late June reported it entered into an agreement with a national sales and brokerage company, that will give its functional water systems and supplement products access to local and national retailers across multiple channels including Walgreens, Costco, and the major national grocery chains. DC Brands has recently announced the release of its new H.A.R.D. Nutrition Functional Water Systems, which it expects will revolutionize the functional beverage category. www.hardnutrition.com.
HANGOVER JOE'S HOLDI (OTCBB: HJOE) is trading up today at $0.40, gaining 0.04 (11.11%) 11:28AM EDT on over 100,000 shares. The Company announced yesterday it obtained the services of GBS Smash! Brands, the leading beverage commercialization team in the industry. Smash! Brands will be responsible for leading the expansion efforts for Hangover Joe's across the US.
Tempco, Inc. (OTCBB: TEMO) is trading up at $0.30, gaining 0.06(25.00%) 10:33AM EDT on light volume. The Company provided an update today where it reported it expects to purchase, from Esio Franchising, LLC (the franchising arm of Esio Beverage Company), its first regional franchise territory, covering the Dallas-Fort Worth, Texas Metropolitan Area, on August 15, 2012
Research beverage stocks with the beverage stocks directory at Investorideas.com - one of the largest beverage stock directories online
http://www.investorideas.com/Beverage_Stocks/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; water and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, natural gas stocks, tech (includes cloud and social networking), defense stocks, nanotech,   China  stocks and agriculture.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member
http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
DC Brands is featured on Running Bull OTC for SMS alerts - Sign up now!
http://www.runningbullotc.com/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas.com and its SMS partner Running Bull OTC have been compensated by HRDN for one month of news, email and sms: twenty five thousand
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact Investorideas.com 800 665 0411

Healthcare and Medical Stock News: Comprehensive Care Corporation (OTCBB: CHCR) Names Colonel Ramon Martinez Senior Management Advisor To Maximize its Market Share with New Pharmacy Initiatives

TAMPA, Fla. - August 2, 2012 (Investorideas.com newswire) Comprehensive Care Corporation ("CompCare" or the "Company") (OTCBB: CHCR), which provides behavioral health, substance abuse and psychotropic pharmacy management services, has retained Ramon Martinez, a U.S. Air Force Lieutenant Colonel, retired, and leading figure in public management at state, national and international levels, as senior advisor to the Company's management. Colonel Martinez will spearhead the development and implementation of a Company mission, vision and strategy design, integrating the Company's behavioral health program with its innovative pharmacy cost containment program. The goal of this initiative is to maximize the Company's market share in both behavioral health and pharmacy management.

"An integral part of the Company's newly designed pharmacy program is the retaining of top-tiered senior advisors to assist the Company in this growth initiative," said Clark A. Marcus, Chairman and CEO. "Management believes that by attracting senior-level business executives to work with our senior management team as advisors, we enhance our ability to reach out to and attract the type of accounts who ultimately benefit the most from the Company's pharmacy cost-containment program."
"We are delighted to have Colonel Martinez join us as the first member of our team of senior advisors," continued Mr. Marcus. "Colonel Martinez's military and public sector background brings a wealth of experience to the Company, and we look forward to having him share with us his creative ideas and vision as to how we might even better enhance our pharmacy initiative. We will also look forward to working with Colonel Martinez in enlarging the scope of the market for our pharmacy initiative beyond that already contemplated by the Company."
Colonel Martinez served a twenty-year military career in the regular component of the US Air Force, climbing the ranks to become Combat Crew Commander, Test Director and Program Manager of Inter-Continental Ballistic Missiles; Assistant Professor of Philosophy at the US Air Force Academy; Deputy Secretary of the Inter-American Defense Board; US National Defense Fellow; Chief of Latin American Strategy of US Southern Command; and Interim Director of the US Southern Command Washington Field Office. He currently serves as senior consultant for XTek Solutions, a national and international consulting firm that uses advanced techniques to empower customers to sustain healthy growth.
Colonel Martinez earned a Master of Arts degree in philosophy from the University of California at Santa Barbara, a Master's degree in public administration from the University of Northern Colorado, and a Bachelor of Arts degree in philosophy and geography from California State University at Long Beach.
Colonel Martinez entered the private sector as Vice President at Genetics & IVF Institute in Fairfax, VA, later served as Assistant Director of Strategic Planning at the South Florida Workforce Board, adjunct professor of philosophy at Miami-Dade Community College, and as a consultant working on Homeland Security issues. He also served as president/CEO of Progreso Latino, Inc., the state of Rhode Island's flagship Latino empowerment agency and largest bilingual, multi-cultural community based organization.
Colonel Martinez is recipient of the Hispanic American Chamber of Commerce of Rhode Island Community Leader of 2009; National Association for the Advancement of Colored People (NAACP) Providence Branch Thurgood Marshall Award of 2008; 2008 Service Person of the Year Award of Sigma Nu Chapter Omega Psi Phi Fraternity, Inc. and The Providence Phoenix Newspaper Local Hero of 2008. He is vice chair and co-founder of the Board of Directors of the Rhode Island Mayoral Academies, and was lauded by the US Secretary of Education as a nationally unique paradigm for public education excellence with a mayor-led regional network of public charter schools serving underserved students. He served as a Trustee of Women and Infants Hospital and the Board of Directors of Clinica Esperanza/Hope Clinic, a free health clinic for the uninsured and underinsured of Rhode Island.
Colonel Martinez said, "Effective behavioral healthcare and pharmacy services are considered two crucial issues that currently impact the overall well-being of consumers and the healthcare economy as a whole. I became interested in CompCare because of its unique operating model designed to address these issues and mutually benefit health plans, self-insured companies and individuals. I am excited to leverage my skills to support CompCare in becoming a thriving, resilient company that delivers on the value promised to its customers. I am also excited to be working with a highly experienced management team who are committed to driving CompCare's growth and competitive market edge. My goal is to work with the management team to introduce a resonating mission, guiding principles, and corporate strategy that propel the Company to the next level."
About CompCare:
Established in 1969, CompCare provides behavioral health, substance abuse and psychotropic pharmacy management services for managed care companies throughout the United States. Headquartered in Tampa, Florida, CompCare focuses on personalized attention, flexibility, a commitment to high-quality services and innovative approaches to behavioral health that address both the specific needs of clients and changing healthcare industry demands. For more information, please call 813-288-4808 or visit our website at www.compcare.com.
Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond CompCare's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, the ability of CompCare to maximize its market share with new pharmacy initiatives, the ability of CompCare and its staff to execute its business plan, the ability of CompCare to offer and sell any of its products at a profit, changes in local, regional, and national economic and political conditions, the effect of governmental regulation, competitive market conditions, varying trends in member utilization, our ability to manage healthcare operating expenses, our ability to achieve expected results from new business, the profitability, if any, of our capitated contracts or other products, increases or variations in cost of care, seasonality, CompCare's ability to obtain additional financing, increased outsourcing of behavioral health services, and additional risk factors as discussed in the reports filed by the company with the Securities and Exchange Commission, which are available on its website at www.sec.gov. Any forward- looking statement in this release speaks only as of the date on which it is made. CompCare assumes no obligation to update or revise any forward-looking statements.
Published at www.investorideas.com newswire
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas.com and its SMS partner Running Bull OTC have been compensated by HRDN for one month of news, email and sms: twenty five thousand
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Biotech and Pharma Stock News: BUYINS.NET Issues Sunshine Biopharma SqueezeTrigger Report

NEWPORT BEACH, Calif. - August 2, 2012 (Investorideas.com Newswire, Biotechindustrystocks.com) BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Sunshine Biopharma (OTC: SBFM) after releasing the latest short sale data through July 31, 2012. The total aggregate number of shares shorted since January 2010 is approximately 3.97 million shares. Approximately 40.11% of daily trading volume is short selling. The SqueezeTrigger price for all SBFM shares shorted is $0.47. A short squeeze is expected to begin when SBFM closes above its $0.47 SqueezeTrigger Price.

Click here to view Report: http://www.buyins.com/ reports/sbfm8-1-12.pdf
Click here for SqueezeTrigger: http://www.buyins.com/ images/sbfmstr8-1-12.jpg
Click here for Friction Factor: http://www.buyins.com/ images/sbfmff8-1-12.jpg
Friction Factor calculates if a fair market is being made in the shares of SBFM. 41% of the previous 37 trading days have been positive or bullish-biased and 59% have been negative or bearish-biased.
Regulation SHO requires bona-fide market-making activities to include making purchases and sales in roughly comparable amounts. The SEC has stated that bona-fide market-making DOES NOT include activity that is related to speculative selling strategies or investment purposes of the broker-dealer and is disproportionate to the usual market making patterns or practices of the broker-dealer in that security. Likewise, where a market-maker posts continually at or near the best offer, but does not also post at or near the best bid, the market-maker's activities would not generally qualify as bona-fide market-making. Moreover, a market-maker that continually executes short sales away from its posted quotes would generally not be considered to be engaging in bona-fide market-making.
BUYINS.NET monitors SBFM market-makers daily for compliance with Fair Market-Making Requirements of Regulation SHO.
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies and comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with "Fair Market-Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.
INVESTMENTS & TRADING
SqueezeTrigger -- 34 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.
GATS -- tracks and quantifies known trading strategies.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. SBFM has paid $1,116 per month to purchase data to be provided in six monthly reports. SBFM has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact:
BUYINS.NET
Thomas Ronk
800-715-9999
tom@buyins.net
http://www.buyins.net
Published at Investorideas.com newswire
Learn more about Sunshine Biopharma Inc. (OTCBB:SBFM): Profile
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: A third party on behalf of SBFM compensates Investorideas.com for news release publishing and distribution : one hundred thousand 144 shares for three months starting June 26th
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Wednesday, August 01, 2012

Biotech Stock Trading News Alert: Sunshine Biopharma (OTCBB: SBFM) Gains over 20%

New York, New York - August 1, 2012 (Investorideas.com Newswire, Biotechindustrystocks.com) Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Sunshine Biopharma Inc. (OTCBB: SBFM). The stock is trading up at $0.4250, gaining $0.0750 or 21.43% on over 70,000 shares.
The Company's most recent news was July 20th when it reported it had engaged Beta Pharma Canada Inc. to manufacture an initial batch of Adva-27a and provide synthesis parameters for future scale-up and large scale manufacturing of the drug.
Adva-27a is Sunshine Biopharma's lead anti-cancer compound which has proven effective at killing Multidrug Resistant Breast Cancer cells (MCF-7/MDR) and Small-Cell Lung Cancer cells (H69AR).
Investorideas.com Newswire Recent Q&A with Mr. Camille Sebaaly, CFO of Sunshine Biopharma Inc. (OTCBB: SBFM) at Investorideas.com
http://www.investorideas.com/CO/SBFM/news/2012/07021.asp

Recent CFA commentary:
http://www.investorideas.com/CO/SBFM/ news/2012/07301.asp
About Sunshine Biopharma Inc. (OTCBB: SBFM):
Sunshine Biopharma is a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company's lead compound, Adva-27a targets aggressive forms of cancer.
www.sunshinebiopharma.com
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, including biotech and pharma stocks. Visit the biotech portal within Investor Ideas: www.biotechindustrystocks.com
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Sign up for the free investor news and biotech stock alerts
Research biotech stocks at the Investor Ideas Biotech stocks Directory
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: A third party on behalf of SBFM compensated Investorideas.com for news release publishing and distribution: one hundred thousand 144 shares for three months starting June 26 th
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Healthcare Stock News; Comprehensive Care (OTCBB: CHCR) Research Report; Price Target of $0.40

New York, New York - August 1, 2012 (Investorideas.com newswire) Investorideas.com, an investor research portal specializing in sector research including biotech and healthcare stocks, releases research coverage and recent news for managed care stock, Comprehensive Care Corporation (OTCBB: CHCR). The Company provides behavioral health, substance abuse and psychotropic pharmacy management services for managed care companies throughout the U.S.

Research from SmallCaps.Us - Issued July 2012
http://smallcaps.us/reports/CR_CHCR_2012_Q2.pdf
'Based on 2012 revenue estimates of $72.5 million and earnings of $1.15 million, we reiterated our buy recommendation for Comprehensive Care Corporation with a price target of $0.40, which is more than double today’s stock price.”
Recent News
Healthcare Stocks: Comprehensive Care Corporation (OTC:CHCR) Retained by CHRISTUS Health to Provide Behavioral Health Management Services
TAMPA, Fla. - July 30, 2012 (Investorideas.com newswire) - Comprehensive Care Corporation (OTCBB: CHCR), which provides behavioral health, substance abuse and psychotropic pharmacy management services for managed care companies throughout the U.S., is pleased to announce that it has been retained by CHRISTUS Health Plan to provide managed behavioral health services to the Medicaid (STAR) and Children's Health Insurance Program (CHIP) populations served in the Nueces Service area, which is comprised of fourteen counties in the Coastal Bend region of Texas.
http://www.investorideas.com/CO/CHCR/news/2012/07301.asp
Profile page at Investorideas.com
http://www.investorideas.com/CO/CHCR/
About CompCare (OTCBB: CHCR) Established in 1969, CompCare provides behavioral health, substance abuse and employee assistance programs for governmental agencies, managed care companies and employer groups throughout the United States. Headquartered in Tampa, Florida, CompCare focuses on personalized attention, flexibility, a commitment to high-quality services and innovative approaches to behavioral health that address both the specific needs of clients and changing healthcare industry demands. For more information, please call 813-288-4808 or visit our website at www.compcare.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
All investment involves risk. The opinion of smallcaps.us is not the opinion or research of Investorideas.com Disclosure: Investorideas.com is compensated for publishing and distributing news for CHCR: four thousand for one month by third party IR firm
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
Contact Investorideas.com
800-665-0411